NL
Navalign LLC Portfolio holdings
AUM
$363M
This Quarter Return
+6.26%
1 Year Return
+10.86%
3 Year Return
+46.65%
5 Year Return
–
10 Year Return
–
AUM
$340M
AUM Growth
+$340M
(+7.2%)
Cap. Flow
+$6.7M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
56.6%
Holding
121
New
6
Increased
62
Reduced
37
Closed
3
Top Buys
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
$6.94M |
| 2 |
Broadcom
AVGO
|
$1.89M |
| 3 |
Fidelity Total Bond ETF
FBND
|
$1.12M |
| 4 |
Vanguard International Dividend Appreciation ETF
VIGI
|
$1.12M |
| 5 |
Apple
AAPL
|
$888K |
Top Sells
| 1 |
Vanguard Total International Stock ETF
VXUS
|
$6.5M |
| 2 |
Blackrock
BLK
|
$1.48M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
$471K |
| 4 |
NVIDIA
NVDA
|
$441K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
$358K |
Sector Composition
| 1 | Technology | 13.01% |
| 2 | Healthcare | 6.25% |
| 3 | Financials | 4.07% |
| 4 | Communication Services | 2.97% |
| 5 | Industrials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Southern California Bancorp
BCAL
$544M
| $337K | 0.1% |
22,800
| – | – |
|
102
iShares S&P 500 Growth ETF
IVW
$62B
| $334K | 0.1% |
3,486
+64
| +2% | +$6.13K |
|
|
103
Vanguard Total International Stock ETF
VXUS
$101B
| $330K | 0.1% |
5,102
-100,456
| -95% | -$6.5M |
|
104
Pfizer
PFE
$140B
| $321K | 0.09% |
11,078
-1,167
| -10% | -$33.8K |
|
105
Paychex
PAYX
$48.8B
| $307K | 0.09% |
2,289
| – | – |
|
106
Abbott
ABT
$228B
| $290K | 0.09% |
2,542
-80
| -3% | -$9.12K |
|
107
iShares Treasury Floating Rate Bond ETF
TFLO
$6.7B
| $281K | 0.08% |
5,550
| – | – |
|
108
Lowe's Companies
LOW
$145B
| $275K | 0.08% |
1,014
| – | – |
|
109
IBM
IBM
$223B
| $247K | 0.07% |
+1,119
| New | +$247K |
|
110
Exxon Mobil
XOM
$488B
| $235K | 0.07% |
2,005
+266
| +15% | +$31.2K |
|
111
Lockheed Martin
LMT
$106B
| $233K | 0.07% |
+398
| New | +$233K |
|
112
Walt Disney
DIS
$211B
| $215K | 0.06% |
+2,237
| New | +$215K |
|
113
Stryker
SYK
$148B
| $213K | 0.06% |
590
| – | – |
|
114
Allogene Therapeutics
ALLO
$255M
| $211K | 0.06% |
75,365
| – | – |
|
115
Vanguard Value ETF
VTV
$143B
| $208K | 0.06% |
+1,191
| New | +$208K |
|
116
Invesco QQQ Trust
QQQ
$358B
| $207K | 0.06% |
425
| – | – |
|
117
Goldman Sachs Access Ultra Short Bond ETF
GSST
$999M
| $205K | 0.06% |
4,049
| – | – |
|
118
AstraZeneca
AZN
$246B
| $205K | 0.06% |
2,625
| – | – |
|
|
119
Blackrock
BLK
$171B
| – | – |
-1,884
| Closed | -$1.48M |
|
120
Cue Biopharma
CUE
$60.9M
| – | – |
-25,000
| Closed | -$31K |
|
121
iShares Core US REIT ETF
USRT
$3.04B
| – | – |
-4,210
| Closed | -$225K |
|